Anti-inflammatory mechanism of α-viniferin regulates lipopolysaccharide-induced release of proinflammatory mediators in BV2 microglial cells

Cellular Immunology

Volumn 290, Issue 1, 2014, Pages 21-29

  Dilshara, Matharage Gayani ^a   Lee, Kyoung Tae ^b   Kim, Hee Ju ^a   Lee, Hak Ju ^b   Choi, Yung Hyun ^c   Lee, Chang Min ^d   Kim, Lark Kyun ^d   Kim, Gi Young ^a  

^a Jeju National University   (South Korea)

^b Korea Forest Research Institute   (South Korea)

^c Dong Eui University   (South Korea)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nitric oxide; Nuclear factor erythroid 2 related factor; Nuclear factor B; Viniferin

Indexed keywords

ALPHA VINIFERIN; CYCLOOXYGENASE 2; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN E2; PROTEIN KINASE B; PYRROLIDINE DITHIOCARBAMATE; RESVERATROL; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CELL DEATH; CELL VIABILITY; CHEMICAL STRUCTURE; CLEMATIS MANDSHURICA; CONTROLLED STUDY; CYTOTOXICITY; DEPHOSPHORYLATION; DNA BINDING; DOWN REGULATION; DRUG ISOLATION; DRUG MECHANISM; ELECTROSPRAY MASS SPECTROMETRY; GENE EXPRESSION; INFLAMMATION; MEDICINAL PLANT; MICROGLIA; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; SIGNAL TRANSDUCTION;

NITRIC OXIDE; NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR; NUCLEAR FACTOR-ΚB; PROSTAGLANDIN E(2); Α-VINIFERIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BENZOFURANS; CELL LINE; CLEMATIS; CYCLOOXYGENASE 2; DINOPROSTONE; HEME OXYGENASE-1; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; MICE; MICROGLIA; NF-E2-RELATED FACTOR 2; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PLANT EXTRACTS; PLANT ROOTS; PROTO-ONCOGENE PROTEINS C-AKT; PYRROLIDINES; RNA INTERFERENCE; RNA, SMALL INTERFERING; THIOCARBAMATES;

EID: 84901301565     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.04.009     Document Type: Article

References (24)

1. Skaper S.D., Giusti P., Facci L. Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J. 2012, 26:3103-3117.
2. Norden D.M., Godbout J.P. Review: microglia of the aged brain: primed to be activated and resistant to regulation. Neuropathol. Appl. Neurobiol. 2013, 39:19-34.
3. Aguirre E., López-Bernardo E., Cadenas S. Functional evidence for nitric oxide production by skeletal-muscle mitochondria from lipopolysaccharide-treated mice. Mitochondrion 2012, 12:126-131.
4. Doherty G.H. Nitric oxide in neurodegeneration: potential benefits of non-steroidal anti-inflammatories. Neurosci. Bull. 2011, 27:366-382.
5. Takuma K., Ago Y., Matsuda T. The glial sodium-calcium exchanger: a new target for nitric oxide-mediated cellular toxicity. Curr. Protein Pep. Sci. 2013, 14:43-50.
6. 2. J. Immunol. 2012, 18:21-28.
7. Mirshafiey A., Jadidi-Niaragh F. Prostaglandins in pathogenesis and treatment of multiple sclerosis. Immunopharmacol. Immunotoxicol. 2010, 32:543-554.
8. Chen Y., Vallee S., Wu J., Vu D., Sondek J., Ghosh G. Inhibition of NF-κB activity by IκBβ in association with κB-Ras. Mol. Cell. Biol. 2004, 24:3048-3056.
9. Surh Y.J., Chun K.S., Cha H.H., Han S.S., Keum Y.S., Park K.K., Lee S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-κB activation. Mutat. Res. 2001, 480-481:243-268.
10. Tak P.P., Firestein G.S. NF-κB: a key role in inflammatory diseases. J. Clin. Invest. 2001, 107:7-11.
11. Perkins N.D. Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 2007, 8:49-62.
12. Salminen A., Kaarniranta K. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-κB signaling. Cell. Signal. 2010, 22:573-577.
13. Correa-Costa M., Amano M.T., Câmara N.O. Cytoprotection behind heme oxygenase-1 in renal diseases. World J. Nephrol. 2012, 1:4-11.
14. Kapturczak M.H., Wasserfall C., Brusko T., Campbell-Thompson M., Elli T.M., Atkinson M.A., Agarwal A. Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse. Am. J. Pathol. 2004, 165:1045-1053.
15. Minamino T., Christou H., Hsieh C.M., Liu Y., Dhawan V., Abraham N.G., Perrella M.A., Mitsialis S.A., Kourembanas S. Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:8798-8803.
16. Surh Y.J., Na H.K. Nf-κB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals. Genes Nutr. 2008, 2:313-317.
17. Kitanaka S., Ikezawa T., Yasukawa K., Yamanouchi S., Takido M., Sung H.K., Kim I.H. (+)-Alpha-viniferin, an anti-inflammatory compound from Caragana chamlagu root. Chem. Pharm. Bull. 1990, 38:432-435.
18. 2 synthase inhibitor from root of Carex humilis. Planta Med. 1998, 64:204-207.
19. Chung E.Y., Roh E., Kwak J.A., Lee H.S., Lee S.H., Lee C.K., Han S.B., Kim Y. α-Viniferin suppresses the signal transducer and activation of transcription-1 (STAT-1)-inducible inflammatory genes in interferon-γ-stimulated macrophages. J. Pharmacol. Sci. 2010, 112:405-414.
20. Chung E.Y., Kim B.H., Lee M.K., Yun Y.P., Lee S.H., Min K.R., Kim Y. Anti-inflammatory effect of the oligomeric stilbene α-viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Med. 2003, 69:710-714.
21. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N. Engl. J. Med. 2001, 345:588-595.
22. Denis P.A. Alzheimer's disease: a gas model. The NADPH oxidase-nitric oxide system as an antibubble biomachinery. Med. Hypotheses 2013, 81:976-987.
23. 2 release from mouse peritoneal macrophages and TNF-α release from rat peripheral blood mononuclear cells. Toxicol. Lett. 2004, 150:191-201.
24. Mamdani M., Juurlink D.N., Lee D.S., Rochon P.A., Kopp A., Naglie G., Austin P.C., Laupacis A., Stukel T.A. Cyclo-oxygenase-2 inhibitors versus non-selective non-steroidal anti-inflammatory drugs and congestive heart failure outcomes in elderly patients: a population-based cohort study. Lancet 2004, 363:1751-1756.